N Saijo

1.1k total citations
48 papers, 877 citations indexed

About

N Saijo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, N Saijo has authored 48 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in N Saijo's work include Lung Cancer Research Studies (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer therapeutics and mechanisms (9 papers). N Saijo is often cited by papers focused on Lung Cancer Research Studies (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer therapeutics and mechanisms (9 papers). N Saijo collaborates with scholars based in Japan, United Kingdom and United States. N Saijo's co-authors include Yasuhiro Fujiwara, Kazuto Nishio, Tohru Ohmori, Kazuo Kasahara, Tamotsu Matsuda, Yoshikazu Sugimoto, Y. Sugimoto, T Matsuda, Kazuo Kasahara and Yutaka Nishiwaki and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Cancer.

In The Last Decade

N Saijo

45 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N Saijo Japan 15 531 425 230 102 85 48 877
Kenneth Steadman United States 16 611 1.2× 543 1.3× 160 0.7× 37 0.4× 101 1.2× 28 1.1k
Hitoshi Arioka Japan 18 504 0.9× 588 1.4× 166 0.7× 119 1.2× 129 1.5× 60 1.1k
Hisao Fukumoto Japan 17 432 0.8× 587 1.4× 193 0.8× 41 0.4× 129 1.5× 30 1.0k
Seiji Doi Japan 12 511 1.0× 365 0.9× 177 0.8× 53 0.5× 58 0.7× 20 737
Anthea Hardcastle United Kingdom 19 410 0.8× 710 1.7× 155 0.7× 127 1.2× 110 1.3× 38 1.3k
Kenji Kitazato Japan 17 296 0.6× 319 0.8× 157 0.7× 22 0.2× 101 1.2× 33 812
Adam Maciejczyk Poland 17 380 0.7× 371 0.9× 140 0.6× 54 0.5× 176 2.1× 85 915
Sarah Sarkar United States 12 356 0.7× 486 1.1× 137 0.6× 47 0.5× 268 3.2× 13 980
Yiqun Zhang United States 17 346 0.7× 288 0.7× 138 0.6× 64 0.6× 143 1.7× 36 805
Michele Tavecchio United States 17 369 0.7× 826 1.9× 210 0.9× 53 0.5× 246 2.9× 24 1.2k

Countries citing papers authored by N Saijo

Since Specialization
Citations

This map shows the geographic impact of N Saijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Saijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Saijo more than expected).

Fields of papers citing papers by N Saijo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Saijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Saijo. The network helps show where N Saijo may publish in the future.

Co-authorship network of co-authors of N Saijo

This figure shows the co-authorship network connecting the top 25 collaborators of N Saijo. A scholar is included among the top collaborators of N Saijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Saijo. N Saijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Saijo, N. (2010). Progress in Cancer Chemotherapy with Special Stress on Molecular-targeted Therapy. Japanese Journal of Clinical Oncology. 40(9). 855–862. 21 indexed citations
3.
Saijo, N, M. Fukuoka, Sumitra Thongprasert, et al.. (2010). Lung Cancer Working Group Report. Japanese Journal of Clinical Oncology. 40(Supplement 1). i7–i12. 16 indexed citations
4.
Ichinose, Y., Takeshi Seto, Yuichiro Ohe, et al.. (2010). Randomized Phase 2 Dose-finding Study of Weekly Administration of Darbepoetin Alfa in Anemic Patients with Lung or Ovarian Cancer Receiving Multicycle Platinum-containing Chemotherapy. Japanese Journal of Clinical Oncology. 40(6). 521–529. 4 indexed citations
5.
Takeda, Kazuhisa, Shunichi Negoro, Masahiro Tanaka, et al.. (2010). A Phase II Study of Cisplatin and Irinotecan As Induction Chemotherapy Followed by Concomitant Thoracic Radiotherapy with Weekly Low-dose Irinotecan in Unresectable, Stage III, Non-Small Cell Lung Cancer: JCOG 9706. Japanese Journal of Clinical Oncology. 41(1). 25–31. 7 indexed citations
6.
Kunitoh, Hideo, Hirotaka Okamoto, Kiichi Watanabe, et al.. (2005). 広範囲疾患小細胞肺癌(ED‐SCLC)の高齢又は予後不良患者におけるカルボプラチン(Cb)又はエトポシド(E)とシスプラチン(P)との多剤併用無作為第III相試験:日本臨床腫瘍学グループ治験報告(JCOG9702). Lung Cancer. 49. 53. 2 indexed citations
7.
Yoshino, Keiichi, Kosei Hirakawa, Toshifusa Nakajima, et al.. (2002). Meeting report of the 74th Congress of the Japanese Gastric Cancer Association. Gastric Cancer. 5(4). 185–193. 4 indexed citations
8.
Sekine, Ikuo & N Saijo. (2001). Growth-Stimulating Pathways in Lung Cancer: Implications for Targets of Therapy. Clinical Lung Cancer. 2(4). 299–306. 2 indexed citations
9.
Kuh, Hyo‐Jeong, et al.. (2000). A Computational Model for Quantitative Analysis of Cell Cycle Arrest and Its Contribution to Overall Growth Inhibition by Anticancer Agents. Japanese Journal of Cancer Research. 91(12). 1303–1313. 6 indexed citations
10.
11.
Nishio, Kazuto, et al.. (1997). Effect of Glutathione Depletion on Cisplatin Resistance in Cancer Cells Transfected with the γ‐Glutamylcysteine Synthetase Gene. Japanese Journal of Cancer Research. 88(2). 108–110. 9 indexed citations
12.
Heike, Yuji, Minako Takahashi, Tatsuo Ohira, et al.. (1997). Genetic immunotherapy by intrapleural, intraperitoneal and subcutaneous injection of IL-2 gene-modified Lewis lung carcinoma cells. International Journal of Cancer. 73(6). 844–849. 16 indexed citations
13.
Oshita, Fumihiro, et al.. (1995). Prospective Evaluation of the Feasibility of Cisplatin‐based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions. Japanese Journal of Cancer Research. 86(12). 1198–1202. 67 indexed citations
14.
Kojima, Akira, Yoshifumi Soejima, Hiroaki Okamoto, et al.. (1994). A Randomized Prospective Study of Imipenem-Cilastatin With or Without Amikacin as an Empirical Antibiotic Treatment for Febrile Neutropenic Patients. American Journal of Clinical Oncology. 17(5). 400–404. 20 indexed citations
15.
Kondō, Hideki, Fumihiko Kanzawa, Kazuto Nishio, Shiro Saito, & N Saijo. (1994). In vitro and in vivo Effects of Cisplatin and Etoposide in Combination on Small Cell Lung Cancer Cell Lines. Japanese Journal of Cancer Research. 85(10). 1050–1056. 9 indexed citations
16.
Miyachi, Sumiki, Kazumasa Noda, Yoshihiro Ohkuni, et al.. (1994). A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer. European Journal of Cancer. 30(2). 188–194. 10 indexed citations
17.
Kasahara, Kazuo, Yasuhiro Fujiwara, Y. Sugimoto, et al.. (1992). Determinants of Response to the DNA Topoisomerase II Inhibitors Doxorubicin and Etoposide in Human Lung Cancer Cell Lines. JNCI Journal of the National Cancer Institute. 84(2). 113–118. 76 indexed citations
18.
Fujiwara, Yasuhiro, et al.. (1990). Determinants of Drug Response in a Cisplatin‐resistant Human Lung Cancer Cell Line. Japanese Journal of Cancer Research. 81(5). 527–535. 69 indexed citations
19.
Tamura, Tomohide, Masanori Sakurai, Yasuhiro Fujiwara, et al.. (1989). Phase I study of combination therapy with interleukin 2 and beta-interferon in patients with advanced malignancy.. PubMed. 49(3). 730–5. 26 indexed citations
20.
Sasaki, Yasutsuna, Fumihiko Kanzawa, Hidenobu Takahashi, et al.. (1987). In vitro antitumor effect of recombinant human tumor necrotizing factor on cultured human cancer cell lines and freshly isolated lung cancer cells by the human tumor clonogenic assay. Investigational New Drugs. 5(4). 353–359. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Steadman Breakdown of academic impact, for papers by Hitoshi Arioka Breakdown of academic impact, for papers by Hisao Fukumoto Breakdown of academic impact, for papers by Seiji Doi Breakdown of academic impact, for papers by Anthea Hardcastle Breakdown of academic impact, for papers by Kenji Kitazato Breakdown of academic impact, for papers by Adam Maciejczyk Breakdown of academic impact, for papers by Sarah Sarkar Breakdown of academic impact, for papers by Yiqun Zhang Breakdown of academic impact, for papers by Michele Tavecchio
Rankless by CCL
2026